scorecardresearch
Add as a preferred source on Google
Wednesday, January 14, 2026
TopicDiabetes

Topic: Diabetes

Yoga, dual therapies — 1st India-specific guidelines for those with both hypertension & diabetes

Key feature of guidelines is emphasis on using multiple methods to measure hypertension, including home BP monitoring. For the first time, yoga is recommended as an adjunct therapy

Blockbuster diabetes & obesity drug gets nod for India launch but may be available only next year

Tirzepatide is a type 2 diabetes and obesity drug sold by US firm Eli Lilly under the brand names Mounjaro and Zepbound. It may take around 6 months for it to be launched in India.

Mega-selling weight-loss & diabetes drug now shown to reduce risk of kidney failure, deaths

Semaglutide once a week reduced risk of adverse outcomes in kidney patients by 24 percent, finds study published in The New England Journal of Medicine.

What’s the 1-hour plasma glucose test & can it detect diabetes risk more accurately

International Diabetes Federation recommends 1-hr plasma glucose test, a more sensitive & practical method. A 1-hPG value of 209 mg/dL or more indicates Type 2 diabetes.

Ozempic makers could be raking in 40,000% profit — study says diabetes drug can be made for $1/month

Doctors Without Borders says new class of drugs & insulin devices could be leading to ‘exorbitant corporate profiteering’. Study published in Journal of the American Medical Association.

It’s the brain, not the gut! What new findings reveal about semaglutide weight-loss drug

Semaglutide mimics GLP-1 hormone released by gut after eating, which attaches itself to GLP-1 receptors in the body. Activated receptors help reduce blood sugar and curb appetite.

Using smartwatch to monitor blood glucose level? US FDA strongly advises against it

US regulator says devices that claim to monitor blood glucose levels in real time without piercing skin may show inaccurate & misleading results and pose risks for people with diabetes.

Can diabetes be ‘reversed’ and who is the ideal candidate? What doctors, health-tech firms say

Research suggests Type 2 diabetes can be 'reversed' early on, but doctors stress importance of healthy habits & say health-tech startups' programmes should be approached cautiously.

India denies nod to ‘1st-ever weekly insulin’ for diabetics, seeks more info from maker Novo Nordisk

Icodec has been touted as a therapy that could eliminate the need for daily or mealtime insulin injections for people with severe diabetes. It has not been approved by any country so far.

Diabetes drug semaglutide offers hope beyond obesity management — kidney, heart & liver health

Study by Australian & Canadian scientists, published in Kidney International, finds that drug may be effective at reducing inflammation — lowering risk of heart & kidney disease.

On Camera

India has 7.4% growth, but faltering tax revenue could have implications in coming fiscal year

In the first eight months of the current fiscal year, New Delhi’s net tax intake didn’t even hit the halfway mark of what it expects to collect by March 31.

Grounded no more: Andhra govt revives no-frills Dagadarthi airport near Nellore to boost south coast link

As Visakhapatnam readies a mega airport, the Andhra Pradesh government has revived its shelved Dagadarthi project, aiming to boost cargo and connectivity on the south coast.

Army chief lambasts Chinese infra push in Shaksgam Valley. ‘We consider it illegal action’

Speaking at annual press conference, Army chief reiterated that India does not recognise 1963 Sino-Pakistan border pact under which Pakistan illegally ceded Shaksgam Valley to China.

Thank you Donald Trump, again. India now has reason to shed fear of trade deals and risky reform

UK, EFTA already in the bag and EU on the way, many members of RCEP except China signed up, and even restrictions on China being lifted, India has changed its mind on trade.